Antimicrobial Stewardship: Shorter and Longer Courses of Antibiotics in Respiratory Tract Infection Before and During the COVID-19 Pandemic at one English Foundation Trust.
Author
Abdelsalam Elshenawy, Rasha
Umaru, Nikkie
Aslanpour, Zoe
Attention
2299/27841
Abstract
This study reveals that shorter duration of antibiotics demonstrates the same appropriateness for infections like CAP, HAP, and COPD as per local antimicrobial guidelines. Conversely, longer antibiotic durations didn't affect Bronchiectasis and Viral pneumonia appropriateness. • This highlights the potential importance of reassessing antibiotic therapy lengths to promote effective antimicrobial stewardship. In accordance with local antimicrobial guidelines, stewardship programs should consider shorter durations of antibiotic therapies to treat acute infections. Additional research is necessitated for managing patients with intricate medical histories. • This research compares the appropriateness of shorter versus longer antibiotic therapy duration, stratified by infection types and therapy duration. For Community-Acquired Pneumonia (CAP), shorter durations (3 or 5 days) showed more appropriateness, with 60 instances, than longer ones (7, 8, or 10 days), with 34 instances. • Hospital-Acquired Pneumonia (HAP) demonstrated greater suitability with a shorter 7-day course (52 instances) than a longer 10 or 15-day course (7 instances). With COPD, a 5-day course (14 instances) was more fitting than a 7-day one (6 instances). However, in the case of Ventilator-Acquired Pneumonia (VAP), Bronchiectasis, and Viral pneumonia, the duration didn't significantly affect appropriateness (Table 1). Table 1. The appropriateness of shorter versus longer antibiotic therapy duration, stratified by infection types and therapy duration.
Publication date
2023-09-14Other links
http://hdl.handle.net/2299/27841Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
WHO AWaRe Classification for Antibiotic Stewardship: Tackling Antimicrobial Resistance - A Descriptive Study from an English NHS Foundation Trust Prior to and During the COVID-19 Pandemic
Elshenawy, Rasha; Umaru, Nikkie; Aslanpour, Zoe (2023-12-11)Antimicrobial resistance (AMR) is a silent and rapidly escalating pandemic, presenting a critical challenge to global health security. During the pandemic, this study was undertaken at a NHS Foundation Trust in the United ... -
Shorter and Longer Antibiotic Durations for Respiratory Infections: To Fight Antimicrobial Resistance—A Retrospective Cross-Sectional Study in a Secondary Care Setting in the UK
Abdelsalam Elshenawy, Rasha; Umaru, Nkiruka; Aslanpour, Zoe (2024-03-06)As antimicrobial resistance (AMR) escalates globally, examining antibiotic treatment durations for respiratory infections becomes increasingly pertinent, especially in the context of the COVID-19 pandemic. In a UK secondary ... -
Analysis in Comparative Study on Antimicrobial Stewardship and Antibiotic Prescribing: 2019 vs. 2020 COVID-19 Era.
Abdelsalam Elshenawy, Rasha (Octopus, 2024-01-08)This research examines antimicrobial stewardship (AMS) and antibiotic prescribing in a UK NHS Foundation Trust before and during the COVID-19 pandemic. It explores the impact of the pandemic on AMR and AMS practices using ...